Author [Year] | Country | Design | Model | Sample size | Age (years) Mean ± SD/median (min–max) | Women (n, %) | Endpoint |
---|---|---|---|---|---|---|---|
Long-term mortality (≥ 6 months) | |||||||
Azevedo [2017] | Brazil | Prospective cohort | Preoperative CRP | D: 17 | D: 82.9 ± 8.9 | D: 7, 41.2% | 6-month mortality |
 |  |  |  | S: 58 | S: 78.4 ± 7.2 | S: 42, 72.4% |  |
Capkin [2021] | Turkey | Retrospective cohort | Preoperative CRP | D: 58 | 78.74 ± 6.88 | D: 25, 36.7% | 1-year mortality |
 |  |  |  | S: 196 |  | S: 124, 63.3% |  |
Choi [2021] | South Korea | Retrospective cohort | Postoperative CRP | D: 43 | D: 82.5 ± 5.8 | D: 27, 62.8% | 1-year mortality |
 |  |  |  | S: 220 | S: 80.0 ± 7.2 | S: 163, 74.1% |  |
Colino [2018] | Spain | Prospective cohort | Preoperative CRP | D: 118 | D: 88.1 ± 6.5 | D: 86, 76.9% | 1-year mortality |
 |  |  |  | S: 391 | S: 84.8 ± 6.9 | S: 317, 81.1% |  |
Gulin [2015] | Croatia | Prospective cohort | Preoperative CRP | D: 67 | D: 86.0 (82.0–89.0) | D: 47, 70.1% | 1-year mortality |
 |  |  |  | S: 169 | S: 79.0 (73.0–85.3) | S: 130, 76.9% |  |
Gumieiro [2013] | Brazil | Prospective cohort | Preoperative CRP | D: 11 | D: 82.5 ± 6.8 | D: 8, 72.7% | 6-month mortality |
 |  |  |  | S: 71 | S: 80.0 ± 7.39 | S: 54, 76.1% |  |
Kim [2016] | Korea | Retrospective cohort | Preoperative CRP | D: 109 | D: 80.2 ± 8.0 | D: 73, 67% | 1-year mortality |
 |  |  | Postoperative CRP | S: 663 | S: 79.3 ± 7.1 | S: 507, 76.5% |  |
McLeod [2022] | United Kingdom | Retrospective cohort | Preoperative CRP | D: 94 | D: 80.9 ± 9.6 | D: 70, 74.5% | 1-year mortality |
 |  |  |  | S: 235 | S: 82.5 ± 10.0 | S: 174, 74% |  |
Sedlář [2015] | Czechia | Prospective cohort | Preoperative CRP | D: 64 | D: 82 ± 8 | D: 47, 73.4% | 5-year mortality |
 |  |  | Postoperative CRP | S: 40 | S: 76 ± 8 | S: 28, 70% |  |
Zhou [2021] | China | Retrospective cohort | Postoperative CRP | D: 26 | N/A | D: 10, 38.5% | 1-year mortality |
 |  |  |  | S: 98 |  | S: 63, 64.3% |  |
Short-term mortality (≤ 30 days) | |||||||
Bae [2021] | Korea | Retrospective cohort | Preoperative CRP | D: 19 | D: 82.5 ± 10.1 | D: 9, 47.4% | Intrahospital mortality |
 |  |  |  | S: 443 | S: 74.0 ± 16.3 | S: 311, 70.2% |  |
Balta [2022] | Turkey | Retrospective cohort | Preoperative CRP | D: 30 | 83.09 ± 8.52 | D: 19, 63.3% | 30‑day mortality |
 |  |  |  | S: 135 |  | S: 76, 56.3% |  |
Çiçek [2021] | Turkey | Retrospective cohort | Preoperative CRP | D: 30 | D: 84.4 ± 6.2 | D: 22, 73.3% | Intrahospital mortality |
 |  |  |  | S: 247 | S: 81.7 ± 7.5 | S: 181, 73.3% |  |
Niessen [2018] | Belgium | Retrospective cohort | Preoperative CRP | D: 16 | D: 85.3 ± 9.1 | N/A | Intrahospital mortality |
 |  |  |  | S: 318 | S: 83.6 ± 7.4 |  |  |